Livzon Biologics Limited announced that it has entered into a capital injection agreement for private placement of common shares for gross proceeds CNY 416,666,667 on January 11, 2021. The transaction will include participation from Lisheng Juyuan and returning investor Joincare Pharmaceutical Group Industry Co.,Ltd. Post the closing, the registered capital of the company will increase from CNY 250,000,000 to CNY 666,666,667. The transaction has been approved by the Livzon Pharmaceutical Group Inc.